An Open-label Phase 1 Trial to Determine the Pharmacokinetics, Pharmacodynamics and Safety of GH001 Administered Via a GH001 Aerosol Delivery System in Healthy Subjects
Phase: PHASE1 | Sponsor: GH Research Ireland Limited | Compound: Psychedelic
- Status
- planned
- Institution
- GH Research Ireland Limited
- Start date
- 2026-04-01
- End date
- 2026-05-01
- Registry ID
- NCT07540494
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.